5Y Capital

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

W. Anthony Brooke

Director

Zhe Chen

Managing Director

Peter Chen

Managing Director

Yu Cheng

Partner

Ziyou Fu

Investor Relations Professional

Hanson Hu

Investment Manager

Lu Huang

Director

Ted Xutian Jing

Managing Director

Levi Liu Kai

Partner

Yantao Lai

Investment Manager

Wentian Lian

VP

Tony Lian

Investment Manager

Sylvia Liu

Investment Manager

Qin Liu

Co-Founder, Investment Director & Board Member

Richard Liu

Founding Partner

Richard Liu

Founding Partner

Weimin Luo

Partner and Senior Consultant

Ken Shi

Founding Partner

Jianming Shi

Director of Business Development

Kejia Tang

Human Resource Director

Ji Tong

Investment Manager

Sixue Wang

Public Relations and Investor Relations Professional

Qiong Xue

CFO

Joanna Xue

Chief Financial Officer

Dan You

Executive Director

Cloris You Youdan

Managing Director

Elwin Yuan

Partner

Ye Yuan

Partner

Oliver Zhang

Investment Manager

Fisher Zhang

Partner

Fei Zhang

Partner

Bo Zhang

Managing Director

Past deals in Shanghai

Epigenic Therapeutics

Seed Round in 2022
Epigenic Therapeutics is a biotech firm that offers gene editing therapy.

LANDBASE

Series B in 2022
LANDBASE is a food brand management company driven by the concept of innovation & fashion. Committed to integrating global R&D and production resources, LANDBASE utilizes frontier food processing technologies to redefine traditional foods and build fashionable foods for the future.

HAI ROBOTICS

Series D in 2022
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

VisionNav Robotics

Series C in 2022
VisionNav Robotics Limited designs, develops, and manufactures industrial vehicle vision driverless navigation equipment for indoor and outdoor scenes. Its products include vision navigation tray unmanned forklift, visual navigation balance heavy unmanned forklift, vision navigation forward-moving unmanned forklift, visual navigation unmanned tractor, and industrial vehicle driverless system solution. The company serves to e-commerce logistics, aviation logistics, third party logistics, retail fast moving goods, and home appliance sectors. The company was founded in 2015 and is based in Shenzhen, China.

Virtue Diagnostics

Series B in 2022
VIRTUE Diagnostics(Suzhou)Co.,Ltd. develops in vitro diagnostic platform. The company offers technology platforms including clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. VIRTUE Diagnostics(Suzhou)Co.,Ltd. was founded in 2019 and is based in Suzhou, China with a research and development office in Singapore.

Treelab

Series A in 2021
Treelab is a Shanghai-based company founded in 2019 that specializes in developing a productivity tool designed for non-technical users to create customized business systems. The platform enables individuals and organizations to develop personalized software applications without the need for programming skills. Treelab's tool is utilized to build solutions across various domains, including project management, sales customer relationship management (CRM), form collection, and human resource management. By empowering users to create their own software, Treelab aims to streamline business processes and enhance productivity.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Vastai Technologies

Series B in 2021
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.

Graphics Origin

Angel Round in 2021
Graphics Origin is a graphics technology company focused on providing advanced productivity tools for 3D content creation.

Laizanbao Technology

Series A in 2021
Lai Zanbao is a cross-border e-commerce business solution service provider, and its target positioning is a one-stop e-commerce integrated service provider in the Southeast Asian market. Based on past experience and data accumulation in the field of e-commerce and its own international warehousing and distribution system, Lai Zanbao provides merchants in Southeast Asia with a full chain of services from supply chain selection, logistics performance, e-commerce operations to localized marketing.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Moore Threads

Series A in 2021
Moore Threads providing GPU (Graphics Processing Unit) technology and services to corporate clients in a wide variety of sectors such as gaming, the creative industry, and artificial intelligence.

Zhongke Guosheng

Angel Round in 2021
Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.

Moody

Series C in 2021
Moody is a developer of disposable colored contact lenses brand. The company's products are well branded and packaged, as well as hygienic for users, enabling consumers to purchase quality color contact lens products.

Axbio

Series B in 2021
Axbio Inc. develops and manufactures technology for genetic sequencing. It offers products, such as stool genome extraction kit, blood genome extraction kit, saliva genome extraction kit, and bacterial genome extraction kit. The company provides sequencing and diagnostic systems, disposable biochips, and reagents. Axbio Inc. was founded in 2016 and is based in Shenzhen, China.

PhiGent Robotics

Seed Round in 2021
PhiGent Robotics offers autonomous driving solutions.

HT Aero

Series A in 2021
HT Aero aspires to be the pioneer of urban air mobility (UAM) and is dedicated to producing safe and intelligent electric flying vehicles. which combine automotive and aerospace technologies to realize domestic air-travel usage at scale.

HAI ROBOTICS

Series D in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

HAI ROBOTICS

Series C in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

Etern

Series B in 2021
Etern is developing small molecule innovative drugs for oncology therapies.

XtalPi

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

Bota Biosciences

Series B in 2021
Bota Biosciences designs and develops synthetic bioengineering technology platform for bio-manufacturing. The company develops cloud databases and intelligent control software suitable for biotechnology development and production. Bota Biosciences was founded in 2019 and is based in Hangzhou, China.

Bombax

Series A in 2021
Xiaoice is an AI company that develops a chatbot that acts as a digital assistant with the capability to understand human conversations. Xiaoice allows cross-platform interactions, enabling users to enjoy the convenience of artificial intelligence. Xiaoice is designed as a teenage girl and is touted as an empathic computing framework focusing on longer back-and-forth conversations with humans instead of simply answering questions or obeying commands like most bots. Its technology covers natural language processing, computer voice, computer vision, and AI content generation.

neoX BIOTECH

Venture Round in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

AgileX

Venture Round in 2021
AgileX Robotics (Dongguan) CO., Ltd designs and manufactures mobile robot products. It offers Unmanned ground vehicle (UGV), automated guided vehicle (AGV), and steering-by-wire modified electric vehicles. It serves logistics transportation, security patrolling, and agricultural and animal husbandry industries. The company was founded in 2017 and is based in Dongguan, China with an additional office in Shenzhen, China.

Triastek

Series B in 2021
Triastek Co. Ltd. manufactures 3D printed pharmaceuticals and related medical equipment. It offers blockbuster drugs, orphan drugs, and complex drug delivery technologies. It also offers drug 3D printing, such as three-dimensional drug structure formulation design, 3D printing pharmaceutical equipment, and drug product development methods for patent families in China, US, Europe, and Japan. The company also owns Melt Extrusion Deposition (MED), a 3D printing technology universally applicable to solid formulations. The company was founded in 2015 and is based in Nanjing, China.

SoupMaster

Series B in 2021
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.

HAI ROBOTICS

Series B in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

Arctic Vision

Series B in 2021
Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a clinical-stage specialty ophthalmology company based in China, focused on developing innovative therapies to meet the unmet clinical needs in ophthalmic diseases. The company has a portfolio of breakthrough technologies aimed at addressing various eye care challenges, including rare diseases through gene therapy. Established by prominent life sciences investors, Arctic Vision is led by a team of experienced professionals from the ophthalmic industry, bringing extensive expertise in research, development, and commercialization of eye care products. The company aims to deliver effective solutions not only in China but also across Asia and globally.

Zhishan Weixin Biotechnology

Series A in 2021
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Pony.ai

Series C in 2021
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

neoX BIOTECH

Series A in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

Liran cosmetics

Series B in 2021
Liran cosmetics operates as a men’s personal care brand. Liran cosmetics provides products catered to men covering skincare, body wash, hair care, body fragrance, and makeup, among others.

Keep

Series F in 2021
Keep is a young team that loves sports and is also a group of Geeks who pursue the ultimate experience. They focus on application development in the field of mobile sports, advocate the spirit of open sharing, do not imitate, do not follow suit, and only do cool products. In the age of their lives, the fitness culture is awakening, there should be more professional tools, a more pure community, and make the body easier. This is what Keep is doing. They hope that through technology-driven, more people will love fitness and enjoy sports.

Galixir

Series A in 2020
Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.

Shukun Technology

Series C in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Horizon Robotics

Series C in 2020
Beijing Horizon Robotics Technology Co., Ltd. develops chips for robots. The company was founded in 2015 and is based in China.

Medbanks

Series E in 2020
Medbanks Network Technology Co. Ltd. provides data processing services to healthcare industry. The company develops multi center database that manages and mines data that reflects China's patient population. Medbanks Network Technology Co. Ltd. was founded in 2014 and is based in Beijing, China.

XKool Technology

Venture Round in 2020
XKool Technology is focuses on applying artificial intelligence solution to urban planning and architectural design. It is committed to assisting urban planning, architectural design and development decisions intelligent, and empowering AI to promote the development of the entire architectural industry. As the leading company to apply artificial intelligence to urban planning and architectural design, XKool has successfully implemented “artificial intelligence design cloud platform” and “artificial intelligence design cloud service” using cutting-edge technologies such as deep learning, machine learning, and big data. Through simple operation and intelligent services in the cloud, XKool would assist design institutes, real estate developers, planning departments to design and decision-making faster and more accurately.

Vastai Technologies

Series A in 2020
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Gongsibao

Series B in 2020
Gongsibao provides an O2O enterprise service platform. Gongsibao was founded in 2014 and is based in Chaoyang, China.

GalaxySpace

Series C in 2020
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Zilliz

Series B in 2020
Zilliz is a technology company founded in 2017 and headquartered in San Francisco, California, with additional offices in China. It specializes in developing an intelligent data processing platform that enhances query performance, utilizing GPU hardware acceleration. Zilliz is renowned for its open-source project Milvus, which focuses on AI-powered unstructured data analysis and vector similarity search. Since its release in 2019, Milvus has gained significant traction, attracting over 400 enterprise users and engaging more than 120 contributors on GitHub. Its applications are diverse, encompassing areas such as image processing, computer vision, natural language processing, speech recognition, recommendation engines, and drug development. In 2020, Milvus became an incubation-stage project at the LF AI & Data Foundation, reflecting its active development and community support.

Pony.ai

Venture Round in 2020
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

Mockuai

Series C in 2020
Mockuai is a company positioned itself as an e-commerce Software-as-a-Service (SaaS) provider for key accounts.

Naxions

Series C in 2020
Beijing Naxions Technology Co., Ltd. develops a communication software solution that offers digital marketing serivces for the medical Internet industry. The company offers data capture, collection, scraping, cleaning, calculation, and presentation services. The application’s features include content sharing, project management, and customer analysis. The company was founded in 2014 and is based in Chaoyang District, China with additional offices Shanghai, China.

XtalPi

Series C in 2020
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

XINGYUN GROUP

Series C in 2020
XINGYUN GROUP is a comprehensive services platform for global commodities in China, devoting to providing global channel operation, distribution, and supply chain services to brands, retailers, and international trade practitioners.

Lele Ketang

Series C in 2020
LeLe Ketang offers online K-12 education services. The company focuses on primary school math and language. LeLe Ketang was founded in 2014 and is based in Beijing, China.

Galixir

Seed Round in 2020
Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.

Arctic Vision

Series A in 2020
Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a clinical-stage specialty ophthalmology company based in China, focused on developing innovative therapies to meet the unmet clinical needs in ophthalmic diseases. The company has a portfolio of breakthrough technologies aimed at addressing various eye care challenges, including rare diseases through gene therapy. Established by prominent life sciences investors, Arctic Vision is led by a team of experienced professionals from the ophthalmic industry, bringing extensive expertise in research, development, and commercialization of eye care products. The company aims to deliver effective solutions not only in China but also across Asia and globally.

neoX BIOTECH

Venture Round in 2020
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

Kuaidian Yuedu

Series C in 2020
Kuaidian Yuedu offers a story reading app.

Polaris Biology

Series B in 2020
Shanghai Polaris Biology Co., Ltd. develops a cell diagnostic technology platform for tumors. Its platform combines artificial intelligence (AI)-based cell analysis models and analyzes dynamic changes of tumors at the cell level. The data collected supports clinical tumor diagnosis and treatment. Shanghai Polaris Biology Co., Ltd. was founded in 2016 and is based in Shanghai, China.

Sensors Data

Series C in 2020
Sensors was founded in 2015 by Sang Wenfeng, former technology manager at Baidu Inc's big data department. It currently provides big data analysis services for over 300 companies, including bike sharing company ofo, Chinese workout mobile app Keep, and video sharing and live streaming app Miaopai.

Keep

Series E in 2020
Keep is a young team that loves sports and is also a group of Geeks who pursue the ultimate experience. They focus on application development in the field of mobile sports, advocate the spirit of open sharing, do not imitate, do not follow suit, and only do cool products. In the age of their lives, the fitness culture is awakening, there should be more professional tools, a more pure community, and make the body easier. This is what Keep is doing. They hope that through technology-driven, more people will love fitness and enjoy sports.

Boohee

Series C in 2020
Boohee provides you with tailor-made weight loss programs, simple and effective weight loss tools, supplemented by slimming courses, weight loss forums and food calorie enquiries, so that you are thin and healthy, thin and beautiful!

Treelab

Seed Round in 2020
Treelab is a Shanghai-based company founded in 2019 that specializes in developing a productivity tool designed for non-technical users to create customized business systems. The platform enables individuals and organizations to develop personalized software applications without the need for programming skills. Treelab's tool is utilized to build solutions across various domains, including project management, sales customer relationship management (CRM), form collection, and human resource management. By empowering users to create their own software, Treelab aims to streamline business processes and enhance productivity.

Lvuzhou VR

Series A in 2020
Lvuzhou VR is a VR game developer

Xinjunte

Series A in 2020
Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices.

Shenshang Keji

Angel Round in 2019
Shenshang Technology designs and develops artificial intelligence software that provides fashion design solutions. The company was founded in 2019 and is based in Beijing, China.

ONES.com

Series B in 2019
ONES.AI is a technology company that provides enterprise-level R&D management solutions. ONES.AI tools include ONES Project for project progress management; ONES Plan for program management; ONES Wiki for repository management); ONES TestCase for test case and test plan management; and ONES Pipeline for continuous integration and delivery management. It has provided services to more than 20,000 enterprises and organizations including People's Daily New Media, Hi Tea, Kingsoft, HKUST Xunfei, and SASAC Research Center. It has mature solutions in the fields of new retail, games, live broadcast, fintech, artificial intelligence, and other fields. ONES.AI was founded in 2015.

Xpeng Motors

Series C in 2019
Xiaopeng Motors is an electric vehicle and technology company that designs and manufactures smart cars. Xiaopeng Motors focuses on local needs and the consumer experience, while also integrating autonomous driving and internet electronic technologies, their vehicles are greater than the sum of their parts. Xpeng Motors is not only dedicated to serving every family with technology but also to become a companion that truly understands you. Xpeng is equipped with experts from top companies in the field such as Tesla, Mercedes-Benz, Porsche, Ford, Mazda, GAC Motor, Alibaba Group, Tencent, Huawei, P&G and Mi, and more. Electric cars, the Internet, and cross-border brand-retail and internet integration have made Xpeng the main pioneer of this industry.

HeyWhale

Series A in 2019
Whales belong to Shanghai Hejin Information Technology Co., Ltd., founded in Shanghai in 2015, and is China's leading collaborative platform for data science innovation. The company has a professional third-party data science community (formerly “Kosai Network”) with more than 60,000 data intelligence talents, international leading data analysis and AI development collaboration tool kescilab (“K-Lab”) and enterprise data intelligence. Development Development Alliance data business.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Taimei Technology

Series E in 2019
Taimei Technology specializes in developing cloud-based software solutions for clinical research and pharmacovigilance, aimed at enhancing efficiency in the biopharmaceutical industry. Founded in 2013 and headquartered in Jiaxing, China, the company offers a wide array of integrated solutions, including electronic data collection, drug randomization, electronic patient-reported outcomes, and medical imaging systems. Its platform supports collaboration among sponsors, clinical sites, contract research organizations (CROs), patients, and regulatory bodies, facilitating comprehensive clinical trial management and drug monitoring. Taimei Technology also provides additional services such as training, consulting, and outsourcing, catering to the needs of pharmaceutical companies and clinical research organizations. With offices in Shanghai and Beijing, Taimei Technology is dedicated to advancing the clinical research landscape through innovative technology.

Lvuzhou VR

Series A in 2019
Lvuzhou VR is a VR game developer

GalaxySpace

Series B in 2019
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

FURRYTAIL

Series A in 2019
“FURRYTAIL ” believes that enterprise innovation in cut-off categories lacks channel integration advantages, and targeting “crowds” can help shape the cultural consumer group and capture the market. Targeting the youngest cat population with the highest life cycle value , "FURRYTAIL Tail Life" cuts into the "crowd brand" construction, and develops the full life cycle value (LTV) of the cat-specific population from the initial stage around the 90-year-old cat population. Incremental user demand development.

XtalPi

Series B in 2019
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

ClickPaaS

Series A in 2019
ClickPaaS is a provider of low code development platform products and solutions based on hpaPaaS that helps SaaS enterprises, consulting firms, and enterprise customers to significantly reduce response times and costs for complex business requirements. ClickPaaS is an innovative technology platform company dedicated to the development and service of the highly productive aPaaS platform, providing fast, high-quality technology platforms for government companies, consulting companies, startups and professional partners.

Huiyizhuo

Seed Round in 2019
Huiyizhuo is a visual team collaboration tool that digitizes the communication and collaboration scenarios of the conference room to make communication more efficient, accurate and convenient. Users can put the materials they need to display in the conference table and interact with other participants in real time.

Xmov

Series A in 2019
Xmov is an AI company focusing on computer vision and computer graphics.

Xbiome

Series A in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Aihuishou

Corporate Round in 2019
Aihuishou.com (爱回收网) is a bidding-based C2B platform for recycling and the sale of selling second-hand electronic items such as mobile phones, laptops, and more. At present, the recyclable mobile categories are more than 30, including Apple, HTC, Motorola, Samsung, and Sony Ericsson. It nearly covers all the popular mobiles in the market and works in the form of bidding purchase, avoiding the possibility of over-low price assessment of second-hand mobile phones and other second-hand electronic products. It facilitates the purchasing of second-hand electronic products of companies and individuals at the highest price, providing users with a one-stop disposal service of idle items, and making contributions to the environmental protection course.

Zhuiyi Technology

Series C in 2019
Zhuiyi Technology is an artificial intelligence company based in Shenzhen, China, specializing in deep learning and natural language processing. The firm develops AI solutions, including a chatbot named YiBot, designed to facilitate interactions between humans and enterprises. Its offerings encompass AI services for semantics, speech, and vision, enabling businesses to enhance customer service, conduct big data analysis, and deliver personalized services. Zhuiyi Technology's AI digital employee intelligence platform can be tailored for various business scenarios, supporting corporate and government functions in marketing, operations, and office tasks. The company serves a diverse range of industries, including finance, Internet, tourism, retail, real estate, and education, positioning itself as a key player in the field of enterprise intelligent services.

Zmjiudian

Series B in 2019
Zmjiudian is a startup company dedicated to the recommendation and reservation of surrounding resort hotels. It is dedicated to business travellers, leisure and holiday users to integrate suitable housing resources, and has a product weekend hotel app, which is a platform for hotel accommodation.

Yunhu Health

Series A in 2019
Hangzhou Yunhu Technology Group Co.,Ltd develops an Internet platform for primary medical services in China. It offers a series of platform-based testing products; and a SaaS based LIS\HIS platform, designed for local medication institutions. It also provides a third party cold chain logistic services to support the blood and drug delivery. The company was founded in 2017 and is based in Hangzhou, China.

Horizon Robotics

Series B in 2019
Beijing Horizon Robotics Technology Co., Ltd. develops chips for robots. The company was founded in 2015 and is based in China.

Shukun Technology

Series B in 2019
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Polaris Biology

Series A in 2019
Shanghai Polaris Biology Co., Ltd. develops a cell diagnostic technology platform for tumors. Its platform combines artificial intelligence (AI)-based cell analysis models and analyzes dynamic changes of tumors at the cell level. The data collected supports clinical tumor diagnosis and treatment. Shanghai Polaris Biology Co., Ltd. was founded in 2016 and is based in Shanghai, China.

FURRYTAIL

Seed Round in 2018
“FURRYTAIL ” believes that enterprise innovation in cut-off categories lacks channel integration advantages, and targeting “crowds” can help shape the cultural consumer group and capture the market. Targeting the youngest cat population with the highest life cycle value , "FURRYTAIL Tail Life" cuts into the "crowd brand" construction, and develops the full life cycle value (LTV) of the cat-specific population from the initial stage around the 90-year-old cat population. Incremental user demand development.

GalaxySpace

Series A in 2018
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Hang

Series C in 2018
Agora, Inc. is a provider of Real-Time Engagement Platform-as-a-Service (RTE-PaaS) that enables developers to incorporate real-time video, voice, and messaging capabilities into their applications. Founded in 2013 and headquartered in Shanghai, the company offers a range of enterprise-grade products, including features for live interactive video and audio streaming, real-time messaging, and recording. Agora's solutions cater to various sectors such as social media, education, entertainment, gaming, healthcare, and financial services. The company operates a Software-Defined Real-Time Network, enhancing the delivery of its services across the globe. Additionally, Agora Lab, founded in 2014 and based in Palo Alto, California, focuses on developing real-time communication solutions, particularly in gaming and social networking. The Agora platform is recognized for its reliability and scalability, making it a widely adopted choice for organizations seeking efficient communication solutions.

Kuaidian Yuedu

Series B in 2018
Kuaidian Yuedu offers a story reading app.